2. Cell Cycle/DNA Damage
  3. Nucleoside Antimetabolite/Analog
  4. 32909-92-5

32909-92-5

Sulfametrole Chemical Structure

32909-92-5

Chemical Structure

  • Sulfametrole
  • CAS No: 32909-92-5
    Formula: C9H10N4O3S2
    Molecular Weight: 286.33
  • IUPAC Name: 4-amino-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide
  • InChIKey: IZOYMGQQVNAMHS-UHFFFAOYSA-N
  • SMILES: O=S(C1=CC=C(N)C=C1)(NC2=NSN=C2OC)=O

Biological Activity: Sulfametrole is an orally active and potent antibacterial. Sulfametrole can be used for infections research, such as HIV, severe pneumonia and UTIs (urinary tract infections)[1][2].

Cat. No. Product Name Purity Description
HY-B1138 Fenbufen 99.33% Fenbufen (CL-82204) is an orally active non-steroidal anti-inflammatory drug (NSAID), with analgetic and antipyretic effects. Fenbufen has potent activity in a variety of animal model, including carageenin edema, UV erythema and adjuvant arthritis. Fenbufen has inhibitory activities against COX-1 and COX-2 with IC50s of 3.9 μM and 8.1 μM, respectively. Fenbufen is a caspases (caspase-1, 3, 4, 5, 9) inhibitor.
HY-B1138R Fenbufen (Standard) ≥98% Fenbufen (Standard) is the analytical standard of Fenbufen. This product is intended for research and analytical applications. Fenbufen (CL-82204) is an orally active non-steroidal anti-inflammatory drug (NSAID), with analgetic and antipyretic effects. Fenbufen has potent activity in a variety of animal model, including carageenin edema, UV erythema and adjuvant arthritis. Fenbufen has inhibitory activities against COX-1 and COX-2 with IC50s of 3.9 μM and 8.1 μM, respectively. Fenbufen is a caspases (caspase-1, 3, 4, 5, 9) inhibitor.
HY-B1138S Fenbufen-d9 Fenbufen-d9 (CL-82204-d9) is the deuterium labeled Fenbufen. Fenbufen (CL-82204) is an orally active non-steroidal anti-inflammatory drug (NSAID), with antipyretic effects. Fenbufen has potent activity in a variety of animal model, including carageenin edema, UV erythema and adjuvant arthritis. Fenbufen has inhibitory activities against COX-1 and COX-2 with IC50s of 3.9 μM and 8.1 μM, respectively. Fenbufen is a caspases (caspase-1, 3, 4, 5, 9) inhibitor.

References

[1]. Koo Chung Hoe, et al. The Crystal and Molecular Structures of Sulfametrole. Bulletin of the Korean Chemical Society. 1982,3(1):9-13.
[2]. Vouloumanou EK, et al. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. Int J Antimicrob Agents. 2011;38(3):197-216. [Content Brief]

Keywords:

Sulfametrole